Skip to main content

Advertisement

Log in

Fever after intravitreal anti-VEGF injections

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ (2007) Pharmacokinetics of intravitreal Bevacizumab (Avastin). Ophthalmology 114:855–859

    Article  PubMed  Google Scholar 

  2. Gaudreault J, Fei D, Rusit J, Suboc P, Shiu V (2005) Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci 46(2):726–733

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Athanasios I. Kotsolis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ladas, I.D., Kotsolis, A.I. Fever after intravitreal anti-VEGF injections. Graefes Arch Clin Exp Ophthalmol 248, 295–296 (2010). https://doi.org/10.1007/s00417-009-1171-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-009-1171-x

Keywords

Navigation